Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jaeger

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Journal of Pediatric Urology|September 19, 2024
The development of surgical ability during pediatric urology fellowship and its evolution in the early years of practiceMatthew R Danzig, Seth A Alpert, Hillary L Copp, et al.
BMC Cancer|November 28, 2008
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]K Hoffmann, H Glimm, B Radeleff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2021
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CTStefan A Koerber, R Finck, K Dendl, et al.
Urology|January 17, 2016
Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone FormersChristopher D Jaeger, Andrew D Rule, Ramila A Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1G M Haag, I Zoernig, J C Hassel, et al.
Leukemia|November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironmentF Fan, M H Bashari, E Morelli, et al.
ESMO Open|March 5, 2022
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical applicationA Echle, N Ghaffari Laleh, P Quirke, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Pediatric Urology|September 19, 2024
The development of surgical ability during pediatric urology fellowship and its evolution in the early years of practiceMatthew R Danzig, Seth A Alpert, Hillary L Copp, et al.
BMC Cancer|November 28, 2008
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]K Hoffmann, H Glimm, B Radeleff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2021
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CTStefan A Koerber, R Finck, K Dendl, et al.
Urology|January 17, 2016
Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone FormersChristopher D Jaeger, Andrew D Rule, Ramila A Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1G M Haag, I Zoernig, J C Hassel, et al.
Leukemia|November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironmentF Fan, M H Bashari, E Morelli, et al.
ESMO Open|March 5, 2022
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical applicationA Echle, N Ghaffari Laleh, P Quirke, et al.
Pageof 9